Investors News Releases News Releases Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Corporate Factsheet Annual Reports News Releases Year None2021202020192018201720162015201420132012201120102009200820072006 Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update Sep 08 2021 Cyclacel Pharmaceuticals Presenting at Three Conferences in September Aug 11 2021 Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update Aug 03 2021 Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update Jul 13 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas Jul 07 2021 Cyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference May 12 2021 Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results May 05 2021 Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update Pagination Current page 1 Page 2 Next page next › Last page last » Toolkit Email AlertsRSS FeedsPrint Page
News Releases Year None2021202020192018201720162015201420132012201120102009200820072006 Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update Sep 08 2021 Cyclacel Pharmaceuticals Presenting at Three Conferences in September Aug 11 2021 Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update Aug 03 2021 Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update Jul 13 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas Jul 07 2021 Cyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference May 12 2021 Cyclacel Pharmaceuticals Reports First Quarter 2021 Financial Results May 05 2021 Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update Pagination Current page 1 Page 2 Next page next › Last page last »
Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes
Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
Aug 11 2021 Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Aug 03 2021 Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update
Jul 13 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Advanced Solid Tumors and Aggressive Lymphomas
Jul 07 2021 Cyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference
May 05 2021 Cyclacel Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Business Update
